Company / R&D per Share
UTAH MEDICAL PRODUCTS INC R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.17
FY2025
5-year range
$0.13 / $0.17
FY2021-FY2025
Trend
+23.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 10 years, ranging from $0.12 in FY2020 to $127.65 in FY2018.
Based on SEC 10-K filings.
0.17 in FY2025 with a 5-year CAGR of +6.6%.
Improved from $0.14 to $0.17 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +8.1%
- 5-Year CAGR
- +6.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 23.6% year-over-year.
- Peak r&d per share was recorded in FY2018.
- Lowest r&d per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.17 | +23.6% |
| FY2024 | $0.14 | -6.3% |
| FY2023 | $0.14 | +9.0% |
| FY2022 | $0.13 | +0.3% |
| FY2021 | $0.13 | +8.7% |
| FY2020 | $0.12 | -99.9% |
| FY2019 | $120.16 | -5.9% |
| FY2018 | $127.65 | +90700.5% |
| FY2017 | $0.14 | +14.6% |
| FY2016 | $0.12 | -6.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026